These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 34412981)

  • 21. Variation in interferon-γ production between QFT-Plus and QFT-GIT assays in TB contact investigation.
    Tsuyuzaki M; Igari H; Okada N; Suzuki K
    Respir Investig; 2019 Nov; 57(6):561-565. PubMed ID: 31402331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients.
    Ryu MR; Park MS; Cho EH; Jung CW; Kim K; Kim SJ; Oh HY; Huh W; Jang HR; Koh WJ; Park HY; Kim YH; Sinn DH; Choi JO; Joh JW; Kim JM; Kim SJ; Park JB; Kang ES
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30135226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicentre verification study of the QuantiFERON
    Pieterman ED; Liqui Lung FG; Verbon A; Bax HI; Ang CW; Berkhout J; Blaauw G; Brandenburg A; van Burgel ND; Claessen A; van Dijk K; Heron M; Hooghiemstra M; Leussenkamp-Hummelink R; van Lochem E; van Loo IHM; Mulder B; Ott A; Pontesilli O; Reuwer A; Rombouts P; Saegeman V; Scholing M; Vainio S; de Steenwinkel JEM
    Tuberculosis (Edinb); 2018 Jan; 108():136-142. PubMed ID: 29523314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serial testing of Mycobacterium tuberculosis infection in Chinese village doctors by QuantiFERON-TB Gold Plus, QuantiFERON-TB Gold in-Tube and T-SPOT.TB.
    Zhang H; Xin H; Wang D; Pan S; Liu Z; Cao X; Wang J; Li X; Feng B; Li M; Yang Q; Zhang M; Jin Q; Gao L
    J Infect; 2019 Apr; 78(4):305-310. PubMed ID: 30710557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD8
    Xin H; Cao X; Feng B; He Y; Guo T; Du J; Shen L; Di Y; Liu Z; Wang D; Zhang B; Zhang Z; Guan X; Shen F; Guan L; Pan S; Duan W; Jin Q; Gao L
    Infect Dis (Lond); 2024 May; 56(5):393-401. PubMed ID: 38319282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the Sensitivity of QuantiFERON-TB Gold In-Tube and T-SPOT.TB According to Patient Age.
    Bae W; Park KU; Song EY; Kim SJ; Lee YJ; Park JS; Cho YJ; Yoon HI; Yim JJ; Lee CT; Lee JH
    PLoS One; 2016; 11(6):e0156917. PubMed ID: 27258377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
    Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
    Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-γ release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis.
    Santin M; Muñoz L; Rigau D
    PLoS One; 2012; 7(3):e32482. PubMed ID: 22403663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon gamma release assays for the diagnosis of latent TB infection in HIV-infected individuals in a low TB burden country.
    Cheallaigh CN; Fitzgerald I; Grace J; Singh GJ; El-Eraki N; Gibbons N; Keane J; Rogers TR; Clarke S; Bergin C
    PLoS One; 2013; 8(1):e53330. PubMed ID: 23382842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positivity rate of interferon-γ release assays for estimating the prevalence of latent tuberculosis infection in renal transplant recipients in Japan.
    Igari H; Akutsu N; Ishikawa S; Aoyama H; Otsuki K; Hasegawa M; Maruyama M; Tsuyuzaki M; Suzuki K; Saigo K
    J Infect Chemother; 2019 Jul; 25(7):537-542. PubMed ID: 30905632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The evaluation of the utility of QuantiFERON TB-Gold In-Tube; QFT-GIT].
    Matsumoto T; Yamazaki T
    Kekkaku; 2014 Sep; 89(9):743-55. PubMed ID: 25730946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD8 response measured by QuantiFERON-TB Gold Plus and tuberculosis disease status.
    Lee MR; Chang CH; Chang LY; Chuang YC; Sun HY; Wang JT; Wang JY
    J Infect; 2019 Apr; 78(4):299-304. PubMed ID: 30707912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
    Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
    Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-1RA in the supernatant of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus is useful for discriminating active tuberculosis from latent infection.
    Akashi S; Suzukawa M; Takeda K; Asari I; Kawashima M; Ohshima N; Inoue E; Sato R; Shimada M; Suzuki J; Yamane A; Tamura A; Ohta K; Tohma S; Teruya K; Nagai H
    J Infect Chemother; 2021 Apr; 27(4):617-624. PubMed ID: 33317988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing QuantiFERON-TB Gold Plus with Other Tests To Diagnose Mycobacterium tuberculosis Infection.
    Venkatappa TK; Punnoose R; Katz DJ; Higgins MP; Banaei N; Graviss EA; Belknap RW; Ho CS
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31462550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube interferon-γ release assays: A systematic review and meta-analysis.
    Pourakbari B; Mamishi S; Benvari S; Mahmoudi S
    Adv Med Sci; 2019 Sep; 64(2):437-443. PubMed ID: 31586819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the change in QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube results after preventive therapy for latent tuberculosis infection.
    Kim OH; Jo KW; Park S; Jo YH; Kim MN; Sung H; Shim TS
    PLoS One; 2020; 15(6):e0234700. PubMed ID: 32544206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study.
    Pérez-Recio S; Pallarès N; Grijota-Camino MD; Sánchez-Montalvá A; Barcia L; Campos-Gutiérrez S; Pomar V; Rabuñal-Rey R; Balcells ME; Gazel D; Montiel N; Vicente D; Goić-Barišić I; Schön T; Paues J; Mareković I; Cacho-Calvo J; Barac A; Goletti D; García-Gasalla M; Barcala JM; Tórtola MT; Anibarro L; Suárez-Toste I; Moga E; Gude-Gonzalez MJ; Naves R; Karslıgil T; Martin-Peñaranda T; Stevanovic G; Trigo M; Rubio V; Karaoğlan İ; Bayram N; Alcaide F; Tebé C; Santin M;
    Microbiol Spectr; 2021 Dec; 9(3):e0097221. PubMed ID: 34756079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of QuantiFERON-TB Gold Plus assays in paediatric tuberculosis: a multicentre PTBNET study.
    Buonsenso D; Noguera-Julian A; Moroni R; Hernández-Bartolomé A; Fritschi N; Lancella L; Cursi L; Soler-Garcia A; Krüger R; Feiterna-Sperling C; Sali M; Lo Vecchio A; Scarano S; Hernanz Lobo A; Espiau M; Soriano-Arandes A; Cetin BS; Brinkmann F; Ozere I; Baquero-Artigao F; Tsolia M; Milheiro Silva T; Bustillo-Alonso M; Martín Nalda A; Mancini M; Starshinova A; Ritz N; Velizarova S; Ferreras-Antolín L; Götzinger F; Bilogortseva O; Chechenyeva V; Tebruegge M; Santiago-García B;
    Thorax; 2023 Mar; 78(3):288-296. PubMed ID: 36283826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of specific CD4 and CD8 T-cell responses in QuantiFERON TB Gold-Plus TB1 and TB2 tubes.
    Allen NP; Swarbrick G; Cansler M; Null M; Salim H; Miyamasu M; Howard J; Boyle J; Lewinsohn D; Lewinsohn D
    Tuberculosis (Edinb); 2018 Dec; 113():239-241. PubMed ID: 30514508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.